Trial intelligence / Profile preview

Fentanyl and Ketorolac vs Fentanyl for PCA After Gynecologic Surgery

NCT05489796Completed

Sponsor
Seoul National University Bundang Hospital
Start
Jun 2022
Primary completion
Aug 2022
Modality
Small Molecules
Countries
1
01

Overview

Randomised trial of ketorolac in postoperative pain (2 arms), sponsored by Seoul National University Bundang Hospital. Primary endpoints: Change in the occurrence of postoperative nausea at 24 hour and Change in the occurrence of postoperative vomiting at 24 hour. Started Jun 2022; status: completed.

02

Drugs

ketorolac
03

Conditions

postoperative pain

Beyond the preview

Go deeper on NCT05489796.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT05489796.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call